| Dr Tahani A Alturkistani, MD | |
|
8 Prospect St, Nashua, NH 03060-3925 | |
| (603) 577-3377 | |
| (603) 577-3387 |
| Full Name | Dr Tahani A Alturkistani |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 8 Prospect St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396975496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 17988 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foundation Medical Partners Inc | 9436140456 | 280 |
| Foundation Medical Partners Inc | 9436140456 | 280 |
News Archive
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In a new study published in the January issue of Radiology, 42 percent of women eligible for breast cancer screening with MRI declined to undergo the procedure.
Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment.
› Verified 8 days ago
| Entity Name | Foundation Medical Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162037 PECOS PAC ID: 9436140456 Enrollment ID: O20040519001048 |
News Archive
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In a new study published in the January issue of Radiology, 42 percent of women eligible for breast cancer screening with MRI declined to undergo the procedure.
Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tahani A Alturkistani, MD Po Box 3677, Nashua, NH 03061-3677 Ph: (603) 577-7900 | Dr Tahani A Alturkistani, MD 8 Prospect St, Nashua, NH 03060-3925 Ph: (603) 577-3377 |
News Archive
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device that can help facilitate minimally invasive surgery.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In a new study published in the January issue of Radiology, 42 percent of women eligible for breast cancer screening with MRI declined to undergo the procedure.
Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment.
› Verified 8 days ago
Dr. Robert Thomas Liscio, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 8 E Pearl St, Nashua, NH 03060 Phone: 603-883-4636 Fax: 603-883-6854 | |
Kelli Pointer, M.D.,PH.D. Radiology Medicare: Medicare Enrolled Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4170 | |
Dr. Daniel Gore Miner, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8 E Pearl St, Nashua, NH 03060 Phone: 603-883-4636 Fax: 603-883-6854 | |
Dr. Robert Jean Carbonneau, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8 E Pearl St, Nashua, NH 03060 Phone: 603-883-4636 Fax: 603-883-6854 | |
Michael J Deleo, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-3377 Fax: 603-577-3387 | |
Matthew J. Daily, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2300 Southwood Drive, Nashua, NH 03063 Phone: 603-577-4070 | |
Dr. Robert Francis Oot, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 8 E Pearl St, Nashua, NH 03060 Phone: 603-883-4636 Fax: 603-883-6854 |